Piperidine

Piperidine

SCHEMBL9525713

C1CCNCC1.N=C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL28384993 1.00 ALDH1A1 (0.60)
SCHEMBL8643744 1.00 ALDH1A1 (0.60)
Piperidine SCHEMBL28388670 1.00 ALDH1A1 (0.60)
Aziridine SCHEMBL7074104 0.86
Aziridine SCHEMBL9284109 0.86 HIF1A (0.42)
Aziridine SCHEMBL6346107 0.86
Piperidine SCHEMBL6275422 0.82
Piperazine SCHEMBL8441646 0.82
Piperazine SCHEMBL11268084 0.82 HIF1A (0.50)
Piperidine SCHEMBL702860 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004112-A1 SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL EVONIK INDUSTRIES AG (DE) 2015-01-01 US disclosed
EP-0550007-A2 Eseroline derivatives having anticholinesterase activity, a process for their preparation and pharmaceutical compositions containing them AESCULAPIUS FARMACEUTICI S.r.l. (IT) 1993-07-07 EP disclosed
EP-0199400-B1 Substituted N-[(4-piperidinyl)alkyl] bicyclic condensed ozazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1990-09-26 EP disclosed
US-4826848-A Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1989-05-02 US disclosed
US-4749702-A PARKINSON*S DISEASE, ENTEROKINESIA JANSSEN PHARMACEUTICA N. V. (BE) 1988-06-07 US disclosed
US-4689330-A PARKINSON DISEASE JANSSEN PHARMACEUTICA N.V. (BE) 1987-08-25 US disclosed
EP-0199400-A2 Substituted N-[(4-piperidinyl)alkyl] bicyclic condensed ozazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-29 EP disclosed